Margarida Vives Espelta

Margarida Vives Espelta

Auto-generated profile, based on publicly available information

Margarida Vives Espelta

Servei de Cirurgia, Hospital Sant Joan de Reus, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili (URV), Institut d’Investigació Sanitària Pere Virgili (IISPV), Avinguda Doctor Josep Laporte 2, 43204 Reus, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2017 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
MVM. Vives
M. Vives
AMA. Molina
A. Molina
MDM. Danús
M. Danús
ERE. Rebenaque
E. Rebenaque
SBS. Blanco
S. Blanco
DCD. Del Castillo
D. Del Castillo

19 December 2016 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
FSFatima Sabench
Fatima Sabench
ALAlicia Molina López
Alicia Molina López
MEMargarida Vives Espelta
Margarida Vives Espelta
ECEsther Raga Carceller
Esther Raga Carceller
SBSantiago Blanco Blasco
Santiago Blanco Blasco
DDDaniel Del Castillo Déjardin
Daniel Del Castillo Déjardin

2 April 2016 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
ALAlicia Molina López
Alicia Molina López
FSFatima Sabench
Fatima Sabench
MEMargarida Vives Espelta
Margarida Vives Espelta
ASAnna Bonada Sanjaume
Anna Bonada Sanjaume
SBSantiago Blanco Blasco
Santiago Blanco Blasco
DDDaniel Del Castillo Déjardin
Daniel Del Castillo Déjardin

17 February 2026 in Cirugía Española
Verified
Journal Article
Closed access
EHElisabet Homs
Elisabet Homs
MVMargarida Vives
Margarida Vives
HTHelena Torrell
Helena Torrell
DCDaniel del Castillo
Daniel del Castillo
ASAntonio Sánchez
Antonio Sánchez
FSFatima Sabench
Fatima Sabench

27 June 2014 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
FSFatima Sabench
Fatima Sabench
MEMargarida Vives Espelta
Margarida Vives Espelta
AVArantxa Cabrera Vilanova
Arantxa Cabrera Vilanova
MGMercè Hernández González
Mercè Hernández González
ARAlbert Feliu Rovira
Albert Feliu Rovira
DDDaniel Del Castillo Déjardin
Daniel Del Castillo Déjardin

Verified
Journal Article
Open access
PDF file
JJJoanna Michalina Jurek
Joanna Michalina Jurek
BXBelen Xifré
Belen Xifré
ERElena Cristina Rusu
Elena Cristina Rusu
HCHelena Clavero-Mestres
Helena Clavero-Mestres
RMRazieh Mahmoudian
Razieh Mahmoudian
TATeresa Auguet
Teresa Auguet
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a liver condition linked to cardiometabolic diseases and mental health issues, with studies highlighting disruptions in gut microbiota activity, including bile acid (BA) metabolism. Therefore, the main aim of this exploratory analysis was to assess microbiota-derived metabolites, specifically BAs and short-chain fatty acids (SCFAs), as potential biomarkers of depressive disorder (DD) in women with morbid obesity at MASLD risk. In this pilot study, 33 females with morbid obesity who were scheduled for bariatric surgery were evaluated. Medical and clinical data were collected, and microbial metabolites from pre-surgery blood samples were analyzed. Patients were stratified according to the presence of DD. Analysis with Spearman’s rank test was used to assess correlations and logistic regression models were built to evaluate biomarkers as predictors of DD risk using both receiver operating characteristic (ROC) and precision–recall curves. In this cohort, 30.3% of females were reported to have DD, in addition to significantly elevated levels of certain BAs and SCFAs, including glycodeoxycholic acid (GDCA) and propionate, which were also correlated with some metabolic biomarkers. However, there were no differences in the incidence of MASLD or metabolic syndrome between patients with DD or without. In conclusion, microbiota-derived metabolites such as GDCA and propionate may influence DD risk in females with morbid obesity; however, their potential use as predictive biomarkers should be further investigated to confirm their role in psycho-metabolic conditions.